https://biotechmorning.com/news/fda-reversal-uniqure-huntingtons-gene-therapy Biotech Morning en 2026-09-03T14:19:17.216Z The FDA Said No. Then It Said Yes. Now This Gene Therapy Could Change Everything. https://biotechmorning.com/news/gsk-hutchmed-kras-egfr-deal Biotech Morning en 2026-09-03T14:18:26.949Z GSK's $1.3B Bet on a Two-Headed Cancer Killer https://biotechmorning.com/news/novartis-argo-5-billion-cardiovascular-deal Biotech Morning en 2026-09-03T14:17:41.347Z Novartis Just Bet $5.2B on a Chinese Biotech You've Never Heard Of https://biotechmorning.com/news/ivonescimab-beats-keytruda-overall-survival-nsclc Biotech Morning en 2026-09-03T14:16:55.323Z The Drug That Just Beat Keytruda at Its Own Game https://biotechmorning.com/news/arpa-h-benchtop-mrna-manufacturing-waterfall-scientific Biotech Morning en 2026-09-03T14:16:10.330Z The Benchtop Machine That Could Replace an Entire mRNA Factory https://biotechmorning.com/news/fda-china-clinical-trial-scrutiny Biotech Morning en 2026-09-03T14:15:27.751Z The FDA Just Put China's Clinical Trial Pipeline on Notice https://biotechmorning.com/news/crispr-deaths-china-viral-vector-delivery-debate Biotech Morning en 2026-09-03T14:14:46.992Z CRISPR's Body Count Is Growing. The Delivery Truck Is the Problem. https://biotechmorning.com/news/teva-celiac-disease-anti-il15-phase-2-win Biotech Morning en 2026-09-03T14:13:56.450Z The Pill That Could Let Celiac Patients Eat Bread Again https://biotechmorning.com/news/tg4050-cancer-vaccine-zero-relapses-three-years Biotech Morning en 2026-09-03T14:13:09.055Z Zero Relapses in Three Years: The Cancer Vaccine That Won't Blink https://biotechmorning.com/news/ultragenyx-angelman-syndrome-phase-3-failure Biotech Morning en 2026-09-03T14:12:25.348Z The Drug That Was Supposed to Change Angelman Syndrome Just Flopped https://biotechmorning.com/news/lilly-deal-spree-venture-capital-recycling Biotech Morning en 2026-09-02T14:22:02.625Z Eli Lilly Spent $25 Billion on Deals This Year. Guess Where All That Cash Went. https://biotechmorning.com/news/lupus-humbled-tyk2-drug-alumis Biotech Morning en 2026-09-02T14:21:16.288Z Lupus Just Humbled Another TYK2 Drug https://biotechmorning.com/news/roche-simcere-trispecific-antibody-deal Biotech Morning en 2026-09-02T14:20:27.774Z Roche Just Paid $75M for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/novartis-3-2b-alteogen-subcutaneous-delivery-deal Biotech Morning en 2026-09-02T14:19:40.451Z Novartis Just Paid $3.2B to Kill the IV Drip https://biotechmorning.com/news/novartis-remibrutinib-ms-cheat-code Biotech Morning en 2026-09-02T14:18:55.008Z Novartis Just Found the Cheat Code for Multiple Sclerosis https://biotechmorning.com/news/arpa-h-125m-rna-manufacturing Biotech Morning en 2026-09-02T14:18:08.228Z The Government Wants to 3D-Print Your RNA Medicine https://biotechmorning.com/news/biomx-tessera-defense-phage-therapy-pivot Biotech Morning en 2026-09-02T14:17:16.895Z From Phage Therapy to Homeland Security: Biotech's Wildest Pivot https://biotechmorning.com/news/regeneron-fop-bone-disease-approval Biotech Morning en 2026-09-02T14:16:28.845Z Regeneron Just Crashed the Rarest Bone Disease Party https://biotechmorning.com/news/novo-oral-wegovy-germany-launch Biotech Morning en 2026-09-02T14:15:47.939Z Novo's Weight-Loss Pill Just Landed in Europe. Now the Real Test Begins. https://biotechmorning.com/news/arsenal-bio-torches-playbook-pivots-in-vivo-car-t Biotech Morning en 2026-09-02T14:15:02.000Z Arsenal Bio Just Torched Its Own Playbook. Here's Why. https://biotechmorning.com/news/mrna-cancer-vaccine-hits-wall Biotech Morning en 2026-09-02T14:14:14.918Z The mRNA Cancer Vaccine That Hit a Wall Nobody Saw Coming